Commodore Capital

Asset Manager

New York, New York, US

Description

Commodore Capital is an investment firm focused on the biopharmaceutical sector, partnering with innovative companies developing genetic medicines and cellular therapies. The company supports smaller biopharmaceutical entities in bringing new, effective medicines to patients globally.

Recent Transactions involving Commodore Capital

Deal	Target	Platform	Buyer	Industry
Aeglea BioTherapeutics Announces Acquisition of Spyre Therapeutics	Spyre Therapeutics	Aeglea BioTherapeutics	EcoR1 Capital Fairmount Funds Management Venrock Healthcare Capital Partners Commodore Capital Perceptive Advisors RTW Investments Cormorant Asset Management Driehaus Capital Management Surveyor Capital Wellington Management Company Undisclosed Institutional Investors Fidelity Management and Research RA Capital Management DeepTrack Capital	Biotechnology Research

Deal

Target

Platform

Buyer

Industry

Aeglea BioTherapeutics Announces Acquisition of Spyre Therapeutics

Spyre Therapeutics

Aeglea BioTherapeutics

EcoR1 Capital

Fairmount Funds Management

Venrock Healthcare Capital Partners

Commodore Capital

Perceptive Advisors

RTW Investments

Cormorant Asset Management

Driehaus Capital Management

Surveyor Capital

Wellington Management Company

Undisclosed Institutional Investors

Fidelity Management and Research

RA Capital Management

DeepTrack Capital

Biotechnology Research

The Lower and Middle Market M&A Platform

See how PrivSource can help you close more deals.

Learn more →